Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OM3 Tear Formulation in Dry Eye Syndrome
NCT02871440Phase 3Completed
- Sponsor
- University of New South Wales
- Start
- Sep 2016
- Primary completion
- Sep 2017
01
Overview
Phase 3, randomised, double-blind trial in dry eye syndrome (DED) (3 arms), sponsored by University of New South Wales. Primary endpoint: Tear Evaporation Rate at 4 weeks. Started Sep 2016; status: completed.
02
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT02871440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02871440.